English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12340/13512 (91%)
Visitors : 2185521 Online Users : 586
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
生技與藥物研究所
謝興邦
--專利
--期刊論文
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
生技與藥物研究所
>
謝興邦
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
謝興邦(Hsing-Pang Hsieh)
ORCID:0000-0002-1332-005X6
Loading...
Collection
專利
[
0
/63]
期刊論文
[
145
/145]
會議論文/會議摘要
[
33
/51]
Siblings
伍素瑩
[
53
/74]
其他
[
58
/60]
夏克山
[
77
/157]
岳嶽
[
29
/34]
張仲明
[
7
/9]
張俊彥
[
19
/20]
張竣評
[
21
/38]
徐祖安
[
170
/241]
李秀珠
[
76
/108]
李靜琪
[
24
/28]
林書玉
[
21
/31]
洪明秀
[
32
/43]
潘秀玲(2009-2013)
[
16
/17]
王文傑
[
13
/15]
王鴻俊
[
7
/7]
石全(2014-2017)
[
36
/105]
童俊維
[
24
/24]
紀雅惠
[
21
/27]
翁紹華
[
23
/43]
莊宏
[
1
/1]
葉修華
[
25
/45]
葉燈光
[
135
/158]
蔣維棠
[
43
/99]
趙宇生(2002-2013)
[
120
/279]
郭靜娟
[
51
/57]
鄒倫
[
28
/68]
陳志豪
[
31
/70]
陳新(2002-2015)
[
53
/68]
陳炯東
[
183
/267]
顏婉菁
[
6
/8]
許明珠(1997-2001)
[
3
/10]
陳淑貞(1998-2001)
[
3
/11]
陳華鍵(1997-2001)
[
9
/9]
Community Statistics
近3年內發表的文件:19(7.34%)
含全文筆數:178(68.73%)
文件下載次數統計
下載大於0次:178(100.00%)
下載大於100次:169(94.94%)
檔案下載總次數:104774(1.85%)
最後更新時間: 2025-03-09 18:45
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
吡咯烷化合物
단백질 키나아제 억제제로서의 융합 다환 화합물
做為蛋白激酶抑制劑的稠合多環化合物
作为蛋白激酶抑制剂的稠合多环化合物
作爲蛋白激酶抑制劑的稠合多環化合物
Fused bicyclic pyrimidine compounds...
Fused bicyclic pyrimidine compounds...
Fused bicyclic pyrimidine compounds...
오로라 키나아제 저해제용 접합 2고리 피리미딘 화합물
Fused bicyclic pyrimidine compounds...
Jump to a point in the index:
(Choose year)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-25 of 259. (11 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2025-01
Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design
Bioorganic Chemistry. 2025 Jan;154:Article number 108019.
2025-01
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-12-30
Novel naphthyridones targeting pannexin 1 for colitis management
Advanced Science. 2024 Dec 30;Article in Press.
2024-12
Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma
International Journal of Biological Macromolecules. 2024 Dec;283(Part 1):Article number 137296.
2024-11-07
Discovery of DYRK1A inhibitors as potential treatment of pancreatic ductal adenocarcinoma (PDAC)
Asia-Pacific Journal of Clinical Oncology. 2024 Nov 07;20:116.
2024-11-07
Novel approach to anti-tumour and anti-SARS-COV-2 drugs by modulating sialylation of N-glycans
Asia-Pacific Journal of Clinical Oncology. 2024 Nov 07;20:116-117.
2024-11
DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration
Journal of Medicinal Chemistry. 2024 Nov 14;67(21):19777-19790.
2024-11
Epithelial cell adhesion molecule induces induces Wnt receptor transcription to promote colorectal cancer progression
Asia-Pacific Journal of Clinical Oncology. 2024 Nov;20:121.
2024-06-24
Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease
European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-06-24
Discovery of dual MER/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment
Journal of Medicinal Chemistry. 2024 Jun 24;Article in Press.
2024-06-18
Method of the preparation of fused multicyclic compounds
US12012400/2024-06-18
2024-06-11
稠合多環化合物之合成方法
TWI844822/2024-06-11
2024-05-09
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2024-04-26
The method of the preparation of fused multicyclic compounds
AU2022201063/2024-04-26
2024-01-09
縮合多環式化合物の調製方法
JP7416842/2024-01-09
2023-11-03
Influence of ring strain on the formation of rearrangement vs cyclization isotwistane products in the acyl radical reaction of bicyclo[2.2.2]octanone
Organic Letters. 2023 Nov 3;25(43):7757-7762.
2023-10-05
A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects
European Journal of Medicinal Chemistry. 2023 Oct 05;258:Article number 115608.
2023-10
Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs
Annals of Oncology. 2023 Oct;34(Suppl. 2):S214.
2023-02-07
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2022-09-12
A critical overview of current progress for COVID-19: Development of vaccines, antiviral drugs, and therapeutic antibodies
Journal of Biomedical Science. 2022 Sep 12;29:Article number 68.
2022-08-09
Recent advances in total synthesis of natural products by masked ortho-benzoquinones
Journal of the Chinese Chemical Society. 2022 Aug 09;69(8):1210-1222.
2022-05-09
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer
Journal of Biomedical Science. 2022 May 9;29:Article number 29.
2022-04-06
Identification of entry inhibitors against delta and omicron variants of SARS-CoV-2
International Journal of Molecular Sciences. 2022 Apr 6;23(7):Article number 4050.
2022-03-11
以雜環化合物作為激酶抑制劑的治療用途
TWI757722/2022-03-11
2022-01-21
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Journal of Biomedical Science. 2022 Jan 21;29:Article number 5.
Showing items 1-25 of 259. (11 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback